Fundación MEDINA (Spain) is a non-profit drug-discovery center focused on natural products. We combine large microbial NP libraries, high-throughput screening, metabolomics/omics and advanced in-vitro assays. We can co-lead WPs on mechanistic stratification, biomarker discovery and early intervention concepts.
Fundación MEDINA seeks to join a consortium for HORIZON-HLTH-2027-02-TOOL-01, offering expertise in metabolomics, mass spectrometry, and biomarker discovery and validation for AI-driven prediction of disease progression and treatment response.
Partner seeks Consortium/Coordinator
Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Fundación MEDINA seeks to join a consortium for HORIZON-HLTH-2027-01-ENVHLTH-02, offering expertise in metabolomics, mass spectrometry and biomarker discovery to investigate climate-related exposures and their impact on the human exposome.
Partner seeks Consortium/Coordinator
Destination 2: HORIZON-HLTH-2027-01-ENVHLTH-02: Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change
Fundación MEDINA seeks to join a consortium for HORIZON-HLTH-2027-01-DISEASE-05, offering expertise in natural product-based drug discovery, microbial screening, bioactive compound identification and optimisation for novel antiviral therapeutics.
Partner seeks Consortium/Coordinator
Destination 3: HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential